Risks of developing unstable angina in female smokers

Authors

DOI:

https://doi.org/10.14739/2310-1210.2020.4.208350

Keywords:

unstable angina, women, smoking, risk factors

Abstract

 

The aim of the study: to determine the prevalence, interrelation and prognostic value of the major risk factors (RF) of unstable angina (UA) in women, depending on smoking habits.

Materials and methods. 225 women (average age 53.80 ± 6.47 years) were examined: 150 women were patients with UA (group I) and 75 healthy women (group II). Depending on the smoking factor, all women were subdivided into subgroups: A (smokers, IA – patients with UA (n = 86), IIA – almost healthy (n = 45)) and B (non-smokers, IB – patients with UA (n = 64)), IIB were almost healthy (n = 30). The examination included an identification of major RF (hypertension, diabetes mellitus, obesity, dyslipidemia (DLP), measurement of total cholesterol, low-density lipoprotein cholesterol (LDL) and high density (HDL), apolipoprotein A1 (ApoA1) and apolipoprotein B (ApoB), C-reactive protein (CRP), fibrinogen (FG), transforming growth factor (TGF-β2), endothelin-1 (ET-1), endothelial NO synthase (eNOS), malonic dialdehyde (MDA), ceruloplasmin (CP). In order to assess the impact of RF on the development of UA, a multifactorial correlation and regression analysis was performed using the Fisher test.

Results. Female smokers (IA) were significantly 1.4–2.5 times more likely to have such RF as hypertension, diabetes mellitus, DLP and obesity than non-smokers (IB), as well as a combination of ≥3 RF (84.9 % vs. 62.5 %) and ≥5 RF (34.9 % vs. 13.9 %). Smoker patients showed severe disorders of lipid metabolism, higher activity of systemic inflammation and endothelial dysfunction. In female smokers (IA), the relative risk of developing UA was associated (P < 0.05) with DLP ((total cholesterol ˃4 mmol (OR = 12.02, CI = 8.12–16.32), LDL ˃1.8 mmol/l (OR = 9.32, CI = 6.13–12.56), HDL ˂1.2 mmol/l (OR = 3.91, CI = 2.12–5.45)), hypertension (OR = 3.49, CI = 2.96–4.25); endothelial dysfunction (ET-1 ˃7.87 pg/ml (OR = 7.44, CI = 2.89–6.21); eNOS ˂180 pg/ml (OR = 3.42, SI = 2.16–4.78); TGF-β2 <168 pg/ml (OR = 4.13; CI = 2.78–5.92)), systemic inflammation and peroxidation activity (CRP ˃3 mg/l (OR = 3.62, CI = 2.15–4.56), MDA ˃0.45 nmol/mg (OR = 2.89, CI = 1.55–3.91), CP ˃380 mg/year (OR = 2.34, CI = 1.46–3.25). Risks of UA development with regard to the above indicators was 1.5–2 times higher in female smokers (IA) compared to nonsmokers (IB), which might account for UA occurrence approximately 8 years earlier in female smokers (IA) than in non-smokers (IB). A strong multiple correlation was found between TGF-β2 and ET-1 (R = 0.60, at Р = 0.000003), as well as a high predicted risk of UA associated with ˃12 smoking years, ET-1 levels ˃30 pg/ml, TGF β2 ˂145 pg/ml, body mass index ˃30 units and CRP ˃14 mg/l.

Conclusions. Smoking is one of the most aggressive factors of unstable angina in women, contributing to the appearance and progression of other major risk factors, which leads to systemic inflammation, peroxidation, endothelial dysfunction and increases the chances of acute coronary heart disease occurrence even in relatively young women.

 

References

Mehta, L. S., Beckie, T. M., DeVon, H. A., Grines, C. L., Krumholz, H. M., Johnson, M. N., Lindley, K. J., Vaccarino, V., Wang, T. Y., Watson, K. E., Wenger, N. K., & American Heart Association Cardiovascular Disease in Women and Special Populations Committee of the Council on Clinical Cardiology, Council on Epidemiology and Prevention, Council on Cardiovascular and Stroke Nursing, and Council on Quality of Care and Outcomes Research. (2016). Acute Myocardial Infarction in Women: A Scientific Statement From the American Heart Association. Circulation, 133(9), 916-947. https://doi.org/10.1161/CIR.0000000000000351

Nguyen, H. L., Saczynski, J. S., Gore, J. M., & Goldberg, R. J. (2010). Age and sex differences in duration of prehospital delay in patients with acute myocardial infarction: a systematic review. Circulation: Cardiovascular quality and outcomes, 3(1), 82-92. https://doi.org/10.1161/CIRCOUTCOMES.109.884361

Yusuf, S., Hawken, S., Ounpuu, S., Dans, T., Avezum, A., Lanas, F., McQueen, M., Budaj, A., Pais, P., Varigos, J., Lisheng, L., & INTERHEART Study Investigators. (2004). Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. The Lancet, 364(9438), 937-952.

https://doi.org/10.1016/S0140 6736(04)17018-9

Njølstad, I., Arnesen, E., & Lund-Larsen, P. G. (1996). Smoking, serum lipids, blood pressure, and sex differences in myocardial infarction. A 12-year follow-up of the Finnmark Study. Circulation, 93(3), 450-456. https://doi.org/10.1161/01.cir.93.3.450

Horbas, I. M. (2010). Epidemiolohichna sytuatsiia shchodo sertsevo-sudynnykh zakhvoriuvan v Ukraini: 30-richne monitoruvannia [Epidemiological situation of cardiovascular diseases in Ukraine: 30-year monitoring]. Praktychna anhiolohiia, (9-10). https://angiology.com.ua/ua-issue-article-357#Epidemiologichna-situaciya-shchodo-sercevo-sudinnih-zahvoryuvan-v-Ukrayini-richne-monitoruvannya [in Ukrainian].

Iversen, B., Jacobsen, B. K., & Løchen, M.-L. (2013). Active and passive smoking and the risk of myocardial infarction in 24,968 men and women during 11 year of follow-up: the Tromsø Study. European journal of epidemiology, 28(8), 659-667. https://doi.org/10.1007/s10654-013-9785-z

Albrektsen, G., Heuch, I., Løchen, M. L., Thelle, D. S., Wilsgaard, T., Njølstad, I., & Bønaa, K. H. (2017). Risk of incident myocardial infarction by gender: Interactions with serum lipids, blood pressure and smoking. The Tromsø Study 1979-2012. Atherosclerosis, 261, 52-59. https://doi.org/10.1016/j.atherosclerosis.2017.04.009

Joshi, N., Shah, C., Mehta, H., & Gokhle, P. (2013). Comparative study of lipid profile on healthy smoker and non smokers. International Journal of Medical Science and Public Health, 2(3), 622-626. https://doi.org/10.5455/ijmsph.2013.210420131

Kar, D., Gillies, C., Zaccardi, F., Webb, D., Seidu, S., Tesfaye, S., Davies, M., & Khunti, K. (2016). Relationship of cardiometabolic parameters in non-smokers, current smokers, and quitters in diabetes: a systematic review and meta-analysis. Cardiovascular diabetology, 15(1), Article 158. https://doi.org/10.1186/s12933-016-0475-5

Pittilo, M. (2000). Cigarette smoking, endothelial injury and cardiovascular disease. International journal of experimental pathology, 81(4), 219-230.

https://doi.org/10.1046/j.1365-2613.2000.00162.x

Bazzano, L. A., He, J., Muntner, P., Vupputuri, S., & Whelton, P. K. (2003). Relationship between cigarette smoking and novel risk factors for cardiovascular disease in the United States. Annals of internal medicine, 138(11), 891-897. https://doi.org/10.7326/0003-4819-138-11-200306030-00010

Roffi, M., Patrono, C., Collet, J. P., Mueller, C., Valgimigli, M., Andreotti, F., Bax, J. J., Borger, M. A., Brotons, C., Chew, D. P., Gencer, B., Hasenfuss, G., Kjeldsen, K., Lancellotti, P., Landmesser, U., Mehilli, J., Mukherjee, D., Storey, R. F., Windecker, S., & ESC Scientific Document Group. (2016). 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). European heart journal, 37(3), 267-315. https://doi.org/10.1093/eurheartj/ehv320

Ministry of Health of Ukraine. (2016, March 03). Pro zatverdzhennya ta vprovadzhennya mediko-tekhnologіchnikh dokumentіv zі standartizatsії medichnoї dopomogi pri gostromu koronarnomu sindromі bez elevatsії segmenta ST [About approval and implementation of medical and technological documents on standardization of medical care in acute coronary syndrome without ST-segment elevation (No. 164)]. https://ips.ligazakon.net/document/MOZ25691

Arday, D. R., Tomar, S. L., Nelson, D. E., Merritt, R. K., Schooley, M. W., & Mowery, P. (1997). State smoking prevalence estimates: a comparison of the Behavioral Risk Factor Surveillance System and current population surveys. American journal of public health, 87(10), 1665-1669. https://doi.org/10.2105/ajph.87.10.1665

Davis, K. C., Murphy-Hoefer, R., Levine, B., King, B. A., Hu, S., & Rodes, R. (2019). Evidence of the Impact of the Tips From Former Smokers Campaign: Results From the Behavioral Risk Factor Surveillance System. Preventing chronic disease, 16, Article E137. https://doi.org/10.5888/pcd16.190110

Moshki, M., Zareie, M., & Hashemizadeh, H. (2015). Sex differences in Acute Myocardial Infarction. Nursing and midwifery studies, 4(1), Article e22395. https://doi.org/10.17795/nmsjournal22395

Egiziano, G., Akhtari, S., Pilote, L., Daskalopoulou, S. S., & GENESIS (GENdEr and Sex DetermInants of Cardiovascular Disease) Investigators. (2013). Sex differences in young patients with acute myocardial infarction. Diabetic medicine, 30(3), Article e108-e114. https://doi.org/10.1111/dme.12084

Dreyer, R. P., Smolderen, K. G., Strait, K. M., Beltrame, J. F., Lichtman, J. H., Lorenze, N. P., D'Onofrio, G., Bueno, H., Krumholz, H. M., & Spertus, J. A. (2016). Gender differences in pre-event health status of young patients with acute myocardial infarction: A VIRGO study analysis. European heart journal: Acute cardiovascular care, 5(1), 43-54. https://doi.org/10.1177/2048872615568967

Aihara, K., Ikeda, Y., Yagi, S., Akaike, M., & Matsumoto, T. (2010). Transforming Growth Factor-β1 as a Common Target Molecule for Development of Cardiovascular Diseases, Renal Insufficiency and Metabolic Syndrome. Cardiology research and practice, 2011, Article 175381. https://doi.org/10.4061/2011/175381

Argmann, C. A., Van Den Diepstraten, C. H., Sawyez, C. G., Edwards, J. Y., Hegele, R. A., Wolfe, B. M., & Huff, M. W. (2001). Transforming growth factor-beta1 inhibits macrophage cholesteryl ester accumulation induced by native and oxidized VLDL remnants. Arteriosclerosis, thrombosis, and vascular biology, 21(12), 2011-2018. https://doi.org/10.1161/hq1201.099426

Millett, E., Peters, S., & Woodward, M. (2018). Sex differences in risk factors for myocardial infarction: cohort study of UK Biobank participants. BMJ, 363, Article k4247. https://doi.org/10.1136/bmj.k4247

Anand, S. S., Islam, S., Rosengren, A., Franzosi, M. G., Steyn, K., Yusufali, A. H., Keltai, M., Diaz, R., Rangarajan, S., Yusuf, S., & INTERHEART Investigators. (2008). Risk factors for myocardial infarction in women and men: insights from the INTERHEART study. European heart journal, 29(7), 932-940. https://doi.org/10.1093/eurheartj/ehn018

Berry, J. D., Dyer, A., Carnethon, M., Tian, L., Greenland, P., & Lloyd-Jones, D. M. (2008). Association of traditional risk factors with cardiovascular death across 0 to 10, 10 to 20, and >20 years follow-up in men and women. American Journal of Cardiology, 101(1), 89-94. https://doi.org/10.1016/j.amjcard.2007.07.079

How to Cite

1.
Solomenchuk TM, Bedzai AO, Protsko VV, Lutska VL. Risks of developing unstable angina in female smokers. Zaporozhye Medical Journal [Internet]. 2020Jul.22 [cited 2024Nov.23];22(4). Available from: http://zmj.zsmu.edu.ua/article/view/208350

Issue

Section

Original research